Clinical Trials
3 trialsNCT06881823 2025-12-29
NeoPSMA
Novartis
Phase 1/2 Withdrawn
NCT06199453 2025-02-10
LuRM_ACC/2023
Maria Sklodowska-Curie National Research Institute of Oncology
Phase 2 Withdrawn
NCT02657447 2019-01-10
Dosimetry Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma (LYMRIT-37-02)
Nordic Nanovector
Phase 1 Withdrawn